cancer research
Article by Fashion201104
The debut sample issue will feature study that enhances the classification of prostate cancer and proposes a probable new therapy, introduces possible new targets for lung cancer, and redefines immunotherapy in breast cancer.
Co-editors in Chief Lewis Cantley, Ph.D., director of the Beth Israel Deaconess Medical Center and professor of Systems Biology at Harvard Medical School, and Jose Baselga, M.D., Ph.D., associate director and chief of the division of hematology/oncology at the Massachusetts General Hospital, will host a press conference on these studies and discuss the implications of the new journal for the field. This press conference is going to be held on Sunday, April three at 1:00 p.m. ET in Room W313 of the Orange County Convention Center.
?